Constructing Conjugated Polymer Composite Fluorescent Nanodrug Materials for Treating Abdominal Aortic Aneurysm

Area of Science:

• Biomaterials Science
• Nanotechnology
• Vascular Biology

Background:

• Abdominal aortic aneurysm (AAA) is a life-threatening condition with no effective drug treatments.
• Early AAA stages are asymptomatic, leading to sudden, fatal ruptures.
• Developing effective therapeutic strategies for AAA is a critical unmet medical need.

Purpose of the Study:

• To develop and characterize a novel chitosan/genipin/zinc oxide (CH/G-ZnO) composite nanoparticle system for drug delivery.
• To investigate the therapeutic potential of Compound 1 loaded CH/G-ZnO nanoparticles (CH/G-ZnO@1) in vascular smooth muscle cells (VSMCs).
• To evaluate the impact of CH/G-ZnO@1 on matrix metalloproteinase (MMP) and collagen type IV alpha 1 chain (COL4A1) expression in VSMCs.

Main Methods:

• Synthesis and characterization of CH/G-ZnO composite nanoparticles.
• Loading of Compound 1 onto CH/G-ZnO nanoparticles to form CH/G-ZnO@1.
• Assessment of CH/G-ZnO@1's light-triggered gelation properties.
• In vitro treatment of VSMCs with CH/G-ZnO@1 and subsequent analysis of MMP and COL4A1 expression and cell proliferation.

Main Results:

• The CH/G-ZnO@1 composite nanoparticles demonstrated light-triggered and rapid gelation.
• Characterization confirmed the structure and performance of the CH/G-ZnO@1 composite.
• Treatment with CH/G-ZnO@1 significantly reduced MMP levels in VSMCs.
• CH/G-ZnO@1 treatment significantly increased COL4A1 expression in VSMCs.
• The composite enhanced the proliferative activity of VSMCs.

Conclusions:

• CH/G-ZnO@1 represents a promising novel drug delivery system for abdominal aortic aneurysm (AAA) therapy.
• The system effectively modulates VSMC behavior by reducing MMP and increasing COL4A1, promoting cell proliferation.
• This approach offers a potential new avenue for developing effective drug treatments for AAA.